微生物衍生的丁酸盐的模仿揭示了强大的肠表皮HIF稳定剂的模板
Alfredo Ornelas1, Nichole Welch1,2, Jacob A Countess1
1Mucosal Inflammation Program and Division of Gastroenterology and Hepatology, University of Colorado, Aurora, CO, USA.
Gut microbes
|October 12, 2023
概括
4-默卡普托丁酸盐 (MBA) 比丁酸盐 (BA) 更有效地稳定缺氧诱导因子 (HIF). 这种代谢物模仿增强了表皮屏障功能,并为与HIF相关的疾病提供了新的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 微生物群衍生的短链脂肪酸,如丁酸盐 (BA),通过调节表皮屏障功能和炎症来提供健康益处.
- 丁酸盐 (BA) 稳定转录因子低氧诱导因子 (HIF),影响细胞生长和分化.
- 对于HIF稳定的最佳代谢物仍然不清楚,这促使人们探索代谢物仿真.
研究的目的:
- 研究代谢物模拟作为一种提高对低氧诱导因子 (HIF) 的生物反应的策略.
- 为了比较4-mercapto butyrate (MBA) 与butyrate (BA) 在稳定HIF中的有效性.
主要方法:
- 利用肠上皮细胞 (IECs) 来评估HIF稳定性和转录活性.
- 进行了体外研究,以评估表皮屏障的形成.
- 在小鼠身上进行了体内研究,以确定系统性HIF稳定.
主要成果:
- 在IEC中,4-mercapto butyrate (MBA) 显示出比butyrate (BA) 更强大的HIF稳定性和更长的生物半衰期.
- 在实验室中,MBA诱导了经典的HIF基因标,并增强了表皮屏障的形成.
- 在体内研究证实了与BA相比,MBA在小鼠中的系统性HIF稳定性优于BA.
结论:
- 4 - 默卡普托丁酸盐 (MBA) 是一个强大的模仿丁酸盐 (BA) 的HIF稳定.
- MBA增强了氧气消耗,其硫基组作为四碳SCFA对HIF稳定至关重要.
- 这些发现为开发针对HIF的治疗应用的新型代谢物类支架提供了基础.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
183
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
183
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
224
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
224
01:23Renewal of Intestinal Stem Cells
2.6K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.6K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
188
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
188
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K